Mylan launches generic Namenda tablets in U.S.
Mylan NV announced the launch of memantine hydrochloride tablets USP, 5 mg and 10 mg, the generic version of Forest's Namenda Tablets, in the United States on Tuesday. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, used for treating moderate to severe Alzheimer's-type dementia. Read More »